Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D8JN6C
|
|||
| Drug Name |
ARO-RAGE
|
|||
| Drug Type |
RNA interference
|
|||
| Indication | Asthma [ICD-11: CA23; ICD-10: J45, J45.8; ICD-9: 493] | Phase 1 | [1] | |
| Company |
Arrowhead Pharmaceuticals Pasadena, CA
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Advanced glycosylation end product-specific receptor messenger RNA (AGER mRNA) | Target Info | Antagonist | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT05533294) A Phase 1 Study Evaluating the Effects of ARO-RAGE Injection for Subcutaneous Administration in Healthy Subjects. U.S.National Institutes of Health. | |||
| REF 2 | Clinical pipeline report, company report or official report of Arrowhead Pharmaceuticals | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.